Literature DB >> 21879479

[Management of thyroid diseases during pregnancy].

Alicja Hubalewska-Dydejczyk1, Andrzej Lewiński, Andrzej Milewicz, Stanisław Radowicki, Ryszard Poręba, Małgorzata Karbownik-Lewińska, Marta Kostecka-Matyja, Małgorzata Trofimiuk-Müldner, Dorota Pach, Arkadiusz Zygmunt, Elżbieta Bandurska-Stankiewicz, Ewa Bar-Andziak, Tomasz Bednarczuk, Monika Buziak-Bereza, Krzysztof Drews, Małgorzata Gietka-Czernel, Maria Górska, Helena Jastrzębska, Roman Junik, Janusz Nauman, Marek Niedziela, Alfred Reroń, Krzysztof Sworczak, Anhelli Syrenicz, Wojciech Zgliczyński.   

Abstract

The management of thyroid disorders during pregnancy is one of the most frequently disputed problems in modern endocrinology. It is widely known that thyroid dysfunction may result in subfertility, and, if inadequately treated during pregnancy, may cause obstetrical complications and influence fetal development. The 2007 Endocrine Society Practice Guideline endorsed with the participation of the Latino America Thyroid Association, the American Thyroid Association, the Asia and Oceania Thyroid Association and the European Thyroid Association, greatly contributed towards uniformity of the management of thyroid disorders during pregnancy and postpartum. Despite the tremendous progress in knowledge on the mutual influence of pregnancy and thyroid in health and disease, there are still important areas of uncertainty. There have been at least a few important studies published in the last 3 years, which influenced the thyroidal care of the expecting mother. It should also be remembered that guidelines may not always be universally applied in all populations with different ethnical, socio-economical, nutritional (including iodine intake) background or exposed to different iodine prophylaxis models. The Task Force for development of guidelines for thyroid dysfunction management in pregnant women was established in 2008. The expert group has recognized the following tasks: development of the coherent model of the management of thyroid dysfunction in pregnant women, identification of the group of women at risk of thyroid dysfunction, who may require endocrine care in the preconception period, during pregnancy and postpartum - that is in other words, the development of Polish recommendations for targeted thyroid disorder case finding during pregnancy, and the development of Polish trimester-specific reference values of thyroid hormones. Comprehensive Polish guidelines developed by the Task Force are to systematize the management of the thyroid disorders in pregnant women in Poland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21879479

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  3 in total

1.  HPLC Analysis of the Urinary Iodine Concentration in Pregnant Women.

Authors:  Aniceta A Mikulska; Dorota Filipowicz; Franciszek K Główka; Ewelina Szczepanek-Parulska; Marek Ruchała; Michał Bartecki; Marta Karaźniewicz-Łada
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

2.  Selenium Status and Supplementation Effects in Pregnancy-A Study on Mother-Child Pairs from a Single-Center Cohort.

Authors:  Dorota Filipowicz; Ewelina Szczepanek-Parulska; Małgorzata Kłobus; Krzysztof Szymanowski; Thilo Samson Chillon; Sabrina Asaad; Qian Sun; Aniceta A Mikulska-Sauermann; Marta Karaźniewicz-Łada; Franciszek K Główka; Dominika Wietrzyk; Lutz Schomburg; Marek Ruchała
Journal:  Nutrients       Date:  2022-07-27       Impact factor: 6.706

3.  Iodine prophylaxis in pregnant women in Poland - where we are? (update 2015).

Authors:  Arkadiusz Zygmunt; Andrzej Lewinski
Journal:  Thyroid Res       Date:  2015-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.